Loading
EB
EPIRUS Biopharmaceuticals, Inc. Stock: price and insider trades · United States
EPIRUS Biopharmaceuticals, Inc.: what insiders have been doing
EPIRUS Biopharmaceuticals, Inc. has a thin disclosure history in our data (latest filing: 11 March 2016). New filings will appear here as soon as they are published. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
14
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Last declaration on 11 March 2016
Declarations14 total
1,044 sharesCommon StockSEC:0001104659-16-104508:0
2,608 sharesCommon StockSEC:0001104659-16-104508:1
1,378 shares@ US$2.8050.0% of flowCommon StockSEC:0001104659-16-104508:2
1,519 sharesCommon StockSEC:0001104659-16-101424:0
9,887 sharesCommon StockSEC:0001104659-16-101424:1
1,044 sharesCommon StockSEC:0001104659-16-101423:0
2,608 sharesCommon StockSEC:0001104659-16-101423:1
1,044 sharesCommon StockSEC:0001104659-16-101426:0
3,073 sharesCommon StockSEC:0001104659-16-101426:1
949 sharesCommon StockSEC:0001104659-16-101427:0
2,134 sharesCommon StockSEC:0001104659-16-101427:1
4,305 shares@ US$2.80100.0% of flowCommon StockSEC:0001104659-16-101424:2
1,379 shares@ US$2.8050.0% of flowCommon StockSEC:0001104659-16-101423:2
1,554 shares@ US$2.80100.0% of flowCommon StockSEC:0001104659-16-101426:2
14 of 14 declarations
About EPIRUS Biopharmaceuticals, Inc.
EPIRUS Biopharmaceuticals, Inc. is a biopharmaceutical company focused on developing biosimilar drugs. It is listed on NASDAQ under the ticker symbol EPRS.
